Pharmaceutical Industry Today
Seasonal Influenza Vaccines Therapeutics Market, 2016: Factors of Influence & Key Indicators by 2024
Seasonal Influenza Vaccines Therapeutics Market: Overview
Influenza vaccine is also called as the flu shot. It is used to protect against the infection of the influenza virus. An influenza vaccine has a mixture of 3 viruses type which includes influenza type B virus strain, influenza type A having the H3N2 virus strain, and influenza type A having the H1N1 virus strain. Influenza is a respiratory illness that is contagious which may lead to mild or severe disease. It may lead to death of the patient. The classification of the influenza virus is done on the basis of H1N1 (influenza A) virus, H3N2 (influenza A) virus, and one or two influenza B viruses. The symptoms shown by the patients include cough, running nose, headache chills, diarrhea, sore throat, body aches, fatigue, and vomiting.
Seasonal Influenza Vaccines Therapeutics Market: Facts
The Australian Influenza Vaccine Committee (AIVC) has assessed and evaluated the data that is related to the strains of influenza that were present in the regions of Australia and the Southern Hemisphere. On the basis of this review, the AIVC recommended the TGA to adopt the September 2016 World Health Organization (WHO) proposals for the strains to be covered by the 2017 seasonal influenza vaccines.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/seasonal-influenza-vaccines-therapeutics
Seasonal Influenza Vaccines Therapeutics Market: Segmentation
The global market for the seasonal influenza vaccines therapeutics is fragmented into its end-users and the treatment type. On the basis of the end-user, the global market is segregated into hospitals, clinics, and medicals. On the basis of the patient type, the market is divided into adolescence, elderly, pediatrics, and adults. On the basis of the treatment type, the global market is categorized into antiviral therapies and vaccines.
Seasonal Influenza Vaccines Therapeutics Market: Growth Factors
The major factors that are driving the seasonal influenza vaccines therapeutics market are wider coverage of the vaccination, growing disease awareness about influenza, and the rise in the support of the government for the immunization purposes against seasonal influenza. There is a huge pipeline of products that are made by the major market players thus making the portfolio of the product strong. The key factors that are restraining the growth of the market are limited production capacity, strict regulations imposed, variable demand, and high level of required investment.
Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/seasonal-influenza-vaccines-therapeutics
Seasonal Influenza Vaccines Therapeutics Market: Regional Analysis
The regions where the seasonal influenza vaccines therapeutics market is expanded includes New Zealand, Taiwan, Hong Kong, India, Japan, Australia, China, Philippines, Singapore, and Malaysia. In the recent years, the market witnessed a healthy growth in the countries such as France, Italy, the U.K., the U.S., Germany, Spain, and Japan. In Asia Pacific region, Philippines have the most attractive market for seasonal influenza vaccines.
Seasonal Influenza Vaccines Therapeutics Market: Competitive Players
The key market players that are involved in the seasonal influenza vaccines therapeutics market include Novartis, MedImmune, Solvay, Hualun Biologicals, Seqirus, MedImmune, GlaxoSmithKline, CSL, Sanofi-Pasteur, Sinovac Biotech, ID Biomedical Corp. of Quebec, and Protein Sciences.
Browse detail report @ https://www.zionmarketresearch.com/report/seasonal-influenza-vaccines-therapeutics
What Reports Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: http://www.zionmarketresearch.com
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!